D. E. Shaw & Co., Inc. Homology Medicines, Inc. Transaction History

D. E. Shaw & Co., Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.39 - $3.12 $59,771 - $134,163	43,001 Added 23.62%	225,047 $443,000
Q1 2022 May 16, 2022	BUY	$2.6 - $4.17 $232,278 - $372,539	89,338 Added 96.36%	182,046 $554,000
Q4 2021 Feb 14, 2022	SELL	$3.64 - $7.78 $588,060 - $1.26 Million	-161,555 Reduced 63.54%	92,708 $338,000
Q3 2021 Nov 15, 2021	SELL	$6.01 - $8.71 $106,190 - $153,896	-17,669 Reduced 6.5%	254,263 $2 Million
Q2 2021 Aug 16, 2021	BUY	$6.02 - $9.64 $1.3 Million - $2.09 Million	216,735 Added 392.66%	271,932 $1.98 Million

Q1 2021 May 17, 2021	BUY	$9.17 - $14.8 $135,917 - $219,365	14,822 Added 36.71%	55,197 $519,000
Q4 2020 Feb 16, 2021	BUY	$8.92 - $13.29 $360,145 - $536,583	40,375 New	40,375 $456,000
Q3 2020 Nov 16, 2020	SELL	$9.94 - $16.59 $702,400 - $1.17 Million	-70,664 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$12.07 - $19.34 $852,914 - $1.37 Million	70,664 New	70,664 $1.07 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.